Europe Nutraceuticals Industry Outlook to 2017 - Improving Economic Conditions to Propel Growth

Europe Nutraceuticals Industry Outlook to 2017 - Improving Economic Conditions to Propel Growth

Regular price $1,350.00 Sale

Published on Apr 01, 2014 - 151 pages

The present report on "Europe Nutraceuticals Industry Outlook to 2017 - Improving Economic Conditions to Propel Growth" gives a comprehensive analysis with past, present and future outlook of the nutraceutical industry. The report discusses the UK, Germany, France and Italy nutraceutical markets with future prospects till 2017. The study also entails major industry segments such as functional food, functional beverages and dietary supplements and sub-segments of the market. Additionally, the report has discussed supporting factors such as ongoing trends and developments, government regulations and has highlighted major players operating in the industry with their market share and profiles.

Europe was the fourth largest regional market for nutraceuticals at a global level in 2012, after Asia-Pacific, North America and Latin America; with a contribution of ~% in the overall global revenues. The growth of nutraceuticals sector has witnessed a considerable slowdown in recent years in Europe, adversely affected by the Euro crisis, which has slowed down the business environment in major countries of the region. Overall, Western European countries such as Britain, Germany, France and Italy constitute the major markets for the nutraceuticals in the continent.

The functional food and beverages market, similar to other markets globally, has maintained supremacy over the nutraceuticals sector, accounting for ~% of the overall revenues in 2012. The sheer expanse of the variety of products included in this category has helped this category to account for majority of the contribution in the nutraceuticals sector. The share of dietary supplements stood at ~% in 2012 in Europe.

The improving market conditions in the coming years are expected to benefit both the consumer and business environment in the region. The companies operating in the nutraceuticals sector are expected to put in efforts to meet the needs of the consumers in increasingly sophisticated manner in the area of health and welfare. The introduction of nutraceuticals targeted at providing specific benefits is expected to urge the consumers to dedicate increasing wallet share to these products. The contributions of the UK and Italy are expected to expand in the next five years. The shares of the UK will incline to ~% by 2017, while that of Italy would be ~% in the same year. Germany and France on the other hand are expected to witness a fall in their revenue shares even though the value growth of the respective markets is expected to reach USD ~ million and ~ million respectively by 2017.

In the coming years, the growth in the major markets of Europe will largely be supported by the companies leveraging on product positioning strategies to target specific health needs of consumers.

KEY TOPICS COVERED IN THE REPORT
  • The market size of the nutraceuticals covers Europe, the UK, France, Germany and Italy in terms of revenues.
  • Market Segmentation of the Europe Nutraceuticals industry on the basis of geography and types of products.
  • Market Segmentation of the UK, Germany, France and Italy Nutraceuticals Industry by functional food and beverage and dietary supplements and sub segmentation by product form, benefit-derived and distribution
  • Government Rules and Regulations prevailing in overall Europe, the UK, Germany, France and Italy Nutraceuticals industries
  • Trends and Developments in the UK, Germany, France and Italy Nutraceuticals industry.
  • Competitive landscape, market shares and company profiles of the major players
  • Future outlook and projections of Europe, the UK, Germany, France and Italy Nutraceuticals industries in terms of revenues


Table of Contents

1. Europe Nutraceuticals Industry Introduction
1.1. Rules and Regulations - Nutraceuticals in Europe
1.2. Europe Nutraceuticals Industry Size by Revenues, 2006-2012
1.3. Europe Nutraceuticals Market Segmentation
1.3.1. By Geography, 2006-2012
1.3.2. By Types of Products, 2006-2012
1.4. Europe Nutraceuticals Industry Future Outlook and Projections, 2013-2017
1.4.1. Cause and Effect Relationship Analysis of Europe Nutraceuticals Industry
2. The UK Nutraceuticals Industry Introduction
2.1. Government Rules and Regulations
2.2. The UK Nutraceuticals Industry Size by Revenues, 2006-2012
2.3. The UK Nutraceuticals Market Segmentation by Type of Products, 2006-2012
2.4. The UK Functional Food and Beverages Market Introduction
2.4.1. The UK Functional Food and Beverages Market Size by Revenues, 2006-2012
2.4.2. The UK Functional Food and Beverages Market Segmentation
2.4.2.1. By Distribution, 2006-2012
2.4.2.2. By Product Form, 2006-2012
2.4.2.2.1. The UK Functional Food Market Introduction and Size, 2006-2012
The UK Functional Food Market Segmentation by Type of Products, 2006-2012
2.4.2.2.2. The UK Functional Beverages Market Introduction and Size, 2006-2012
2.4.3. Market Share of Major Brands in the UK Functional Food and Beverages Market, 2006-2012
2.4.4. The UK Functional Food and Beverages Market Trends and Developments
2.4.5. The UK Functional Food and Beverages Market Future Outlook and Projections, 2013-2017
2.5. The UK Dietary Supplements Market Introduction
2.5.1. The UK Dietary Supplements Market Size by Revenues, 2006-2012
2.5.2. The UK Dietary Supplements Market Segmentation by Nutrients, 2011-2012
2.5.3. The UK Dietary Supplements Market Trends and Developments
2.5.4. The UK Dietary Supplements Market Future Outlook and Projections, 2013-2017
2.6. The UK Nutraceuticals Market Future Projections, 2013-2017
2.7. Macroeconomic factors affecting the UK Nutraceuticals Industry
2.7.1. Population Aged 65 and Above in the UK, 2006-2017
2.7.2. Urban Population in the UK, 2006-2017
2.7.3. Public Health Expenditure in the UK, 2006-2017
2.7.4. Out-Of-Pocket Health Expenditure in the UK, 2006-2017
3. Germany Nutraceuticals Industry Introduction
3.1. Government Rules and Regulations
3.2. Germany Nutraceuticals Industry Size by Revenues, 2006-2012
3.3. Germany Nutraceuticals Market Segmentation by Types of Products, 2006-2012
3.4. Germany Functional Food and Beverages Market Introduction and Size, 2006-2012
3.4.1. Germany Functional Food and Beverages Market Segmentation by Product Form, 2012
3.5. Germany Dietary Supplements Market Introduction and Size, 2006-2012
3.6. Germany Nutraceuticals Market Competitive Landscape
3.7. Germany Nutraceuticals Market Trends and Developments
3.8. Germany Nutraceuticals Market Future Outlook and Projections, 2013-2017
3.9. Macroeconomic Factors Affecting Germany Nutraceuticals Industry


Companies Mentioned:

Suntory
Groupe Danone
Kellogg Co.
GlaxoSmithKline GmbH
MCM Klosterfrau Vertriebsgesellschaft mbH
Dirk Rossmann GmbH
Arkopharma Pharmaceutical laboratories SA
Sodiaal International SA